NDC properties for "Thalomid 100 MG Oral Capsule" (RxCUI 404449)
About this data
The tables show NDC propoerties for Thalomid 100 MG Oral Capsule with the RxCUI 404449
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Thalomid 100 MG Oral Capsule (RxCUI 404449)
| MMSL_CODE | BD8901 |
|---|---|
| NDA | NDA020785 |
| RxCUI | 404449 |
| SPL_SET_ID | 2eda833b-1357-4ed4-a093-194524fcb061 |
| Prescribable Synonym | Thalomid 100 MG Oral Capsule |
| RXNAV_STR | Thalomid 100 MG Oral Capsule |
| RxNorm Name | thalidomide 100 MG Oral Capsule [Thalomid] |
| RxNorm Synonym | Thalomid 100 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 404449) |
NDC Properties
NDC Item 59572021015
| NDC 9 | 59572-210 |
|---|---|
| NDC 10 | 59572-210-15 |
| NDC Item | 59572021015 |
| Packaging | 28 in 1 BLISTER PACK |
| COLORTEXT | BROWN |
| Color | C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;100;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2003-06-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-210 |
NDC Item 59572021095
| NDC 9 | 59572-210 |
|---|---|
| NDC 10 | 59572-210-95 |
| NDC Item | 59572021095 |
| Packaging | 5 BLISTER PACK in 1 BOX (59572-210-95) / 28 CAPSULE in 1 BLISTER PACK (59572-210-15) |
| COLORTEXT | BROWN |
| Color | C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;100;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2003-06-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-210 |
NDC Item 59572021015
| NDC 9 | 59572-210 |
|---|---|
| NDC 10 | 59572-210-15 |
| NDC Item | 59572021015 |
| Packaging | 28 in 1 BLISTER PACK |
| COLORTEXT | BROWN |
| Color | C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;100;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2003-06-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-210 |
NDC Item 59572021095
| NDC 9 | 59572-210 |
|---|---|
| NDC 10 | 59572-210-95 |
| NDC Item | 59572021095 |
| Packaging | 5 BLISTER PACK in 1 BOX (59572-210-95) / 28 CAPSULE in 1 BLISTER PACK (59572-210-15) |
| COLORTEXT | BROWN |
| Color | C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;100;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2003-06-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-210 |